RhumbLine Advisers’s Citius Pharmaceuticals CTXR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-1,202
| Closed | -$17.5K | – | 4229 |
|
|
2024
Q2 | $17.5K | Sell |
1,202
-5,072
| -81% | -$74K | ﹤0.01% | 3890 |
|
|
2024
Q1 | $141K | Buy |
6,274
+269
| +4% | +$6.03K | ﹤0.01% | 3328 |
|
|
2023
Q4 | $114K | Sell |
6,005
-55
| -0.9% | -$1.04K | ﹤0.01% | 3411 |
|
|
2023
Q3 | $104K | Buy |
6,060
+291
| +5% | +$4.98K | ﹤0.01% | 3451 |
|
|
2023
Q2 | $173K | Buy |
+5,769
| New | +$173K | ﹤0.01% | 3313 |
|
|
2022
Q2 | – | Sell |
-4,992
| Closed | -$223K | – | 3126 |
|
|
2022
Q1 | $223K | Buy |
4,992
+833
| +20% | +$37.2K | ﹤0.01% | 2731 |
|
|
2021
Q4 | $160K | Sell |
4,159
-158
| -4% | -$6.08K | ﹤0.01% | 2881 |
|
|
2021
Q3 | $219K | Buy |
4,317
+156
| +4% | +$7.91K | ﹤0.01% | 2876 |
|
|
2021
Q2 | $362K | Buy |
+4,161
| New | +$362K | ﹤0.01% | 2713 |
|